Takeda Pharmaceutical Company Limited Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2019-12-16: Form 6-K; Period of report 2019-12-16; Description FORM 6-K; Document form6k_121619.htm.
- 2019-11-29: Form 6-K; Period of report 2019-11-29; Description FORM 6-K; Document form6k_112919.htm.
- 2019-11-21: Form 6-K; Period of report 2019-11-21; Description FORM 6-K; Document form6k_112119.htm.
- 2019-11-15: Form 6-K; Period of report 2019-11-15; Description FORM 6-K; Document form6k_111519.htm.